Your browser doesn't support javascript.
loading
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.
Ciriaco, Nikaoly; Zamora, Esther; Escrivá-de-Romaní, Santiago; Miranda Gómez, Ignacio; Jiménez Flores, José; Saura, Cristina; Sloane, Hillary; Starus, Anna; Fredebohm, Johannes; Georgieva, Lucy; Speight, Graham; Jones, Frederick; Ramón Y Cajal, Santiago; Espinosa-Bravo, Martín; Peg, Vicente.
Afiliação
  • Ciriaco N; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Zamora E; Universidad Autónoma de Barcelona, Barcelona, Spain.
  • Escrivá-de-Romaní S; Universidad Autónoma de Barcelona, Barcelona, Spain.
  • Miranda Gómez I; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Jiménez Flores J; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Saura C; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Sloane H; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Starus A; Radiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Fredebohm J; Molecular Oncology Lab. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Georgieva L; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Speight G; Sysmex Inostics, Inc., Baltimore, MD, USA.
  • Jones F; Sysmex Inostics GmbH, Hamburg, Germany.
  • Ramón Y Cajal S; Sysmex Inostics, Inc., Baltimore, MD, USA.
  • Espinosa-Bravo M; Sysmex Inostics GmbH, Hamburg, Germany.
  • Peg V; Sysmex Inostics, Inc., Baltimore, MD, USA.
Ther Adv Med Oncol ; 14: 17588359221139601, 2022.
Article em En | MEDLINE | ID: mdl-36479470

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha